118 HR 7418 IH: To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. U.S. House of Representatives 2024-02-20 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I118th CONGRESS2d SessionH. R. 7418IN THE HOUSE OF REPRESENTATIVESFebruary 20, 2024Mr. Kelly of Pennsylvania (for himself and Ms. Houlahan) introduced the following bill; which was referred to the Committee on Ways and MeansA BILLTo amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.

1.

Exclusion of compensation provided to participants in clinical trials

(a)

In general

Part III of subchapter B of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting after section 139I the following new section:

139J.

Clinical trial payments

(a)

In general

Gross income shall not include any amount received by an individual as a qualified clinical trial payment. (b)

Qualified clinical trial payment defined

For purposes of this section, the term qualified clinical trial payment means any amount paid to an individual— (1)as compensation for participation by the individual or a dependent of the individual in an approved clinical trial, or (2)to reimburse or pay reasonable and necessary expenses incurred in connection with participation by the individual or a dependent of the individual in an approved clinical trial. (c)

Other definitions

For purposes of this section— (1)

Approved clinical trial

The term approved clinical trial has the meaning given such term in section 2709(d)(1) of the Public Health Service Act (42 U.S.C. 300gg–8(d)(1)), determined by applying disease or condition for life-threatening disease or condition. (2)

Dependent

The term dependent has the meaning given such term in section 152.

. (b)

Clerical amendment

The table of sections for part III of subchapter B of chapter 1 of such Code is amended by inserting after the item relating to section 139I the following new item: Sec. 139J. Clinical trial payments.. (c)

Effective date

The amendment made by this section shall apply to amounts paid after December 31, 2023.